$0.000600
0.0004200.00%
At close: -
$0.078300
0.0812950.00%
After Hours: Jul 5, 4:00 PM EDT
eFFECTOR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of eFFECTOR Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-2.16 | $-2.16 | 0.00 % |
Dec 2023 | 2024-03-25 | $-3.42 | $-1.65 | -107.3 % |
Sep 2023 | 2023-11-13 | $-3.25 | $-3.00 | -8.33 % |
Jun 2023 | 2023-08-08 | $-4.25 | $-5.00 | 15.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-08 | $674.00K | $660.00K | 2.12 % |
Sep 2022 | 2022-11-07 | $867.00K | $640.00K | 35.5 % |
Jun 2022 | 2022-08-09 | $2.01M | $520.00K | 286.7 % |
Mar 2022 | 2022-05-10 | $0 | $350.00K | -100.0 % |
eFFECTOR Therapeutics (EFTR) is scheduled to report earnings on December 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-2.16, which hit the estimate of $-2.16.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.